Is chemodenervation with incobotulinumtoxinA an alternative to invasive chronic anal fissure treatments?
Abstract Background Botulinum toxin type A is currently strongly recommended for the treatment of anal fissures (AFs). However, there is still no consensus on dosage or injection technique. This study provides further efficacy and safety evidence in a 2-year follow-up. Method Prospective, open-label...
| Published in: | BMC Gastroenterology |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-09-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12876-024-03428-z |
